International Cancer Genome Consortium, Hudson TJ, Anderson W, et al. International network of cancer genome projects. Nature. 2010;464(7291):993-8. doi:10.1038/nature08987
Parfenov M, Pedamallu CS, Gehlenborg N, et al. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014;111(43):15544-9. doi:10.1073/pnas.1416074111
Wilkerson MD, Cabanski CR, Sun W, et al. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Nucleic Acids Res. 2014;42(13):e107. doi:10.1093/nar/gku489
Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505(7484):495-501. doi:10.1038/nature12912
Garraway LA, Lander ES. Lessons from the cancer genome. Cell. 2013;153(1):17-37. doi:10.1016/j.cell.2013.03.002
Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150(6):1107-20. doi:10.1016/j.cell.2012.08.029
Smith R, Owen LA, Trem DJ, et al. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing’s sarcoma. Cancer Cell. 2006;9(5):405-16. doi:10.1016/j.ccr.2006.04.004
Getz G, Höfling H, Mesirov JP, et al. Comment on "The consensus coding sequences of human breast and colorectal cancers". Science. 2007;317(5844):1500. doi:10.1126/science.1138764
Berger MF, Garraway LA. Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am. 2009;23(3):397-414, vii. doi:10.1016/j.hoc.2009.03.005